Mechanism of Fuzheng Kang'ai Formula (扶正抗癌方) Regulating Tumor Microenvironment in Non-Small Cell Lung Cancer

Y Tian, S Fu, B Li, L Yuan, Z Bing - Chinese journal of integrative medicine, 2022 - Springer
… the core target genes of FZKA for LUAD by matching the target … disease treatment with
differential genes related to tumor … of new anticancer drugs that are more specific to tumor

[HTML][HTML] 单细胞RNA 测序技术在非小细胞肺癌研究中的应用

张雯晴, 田书凝, 冯振卿 - 南京医科大学学报(自然科学版), 2023 - jnmu.njmu.edu.cn
… Using this technology,it is expected to find new targets for the cancer treatment and further …
肺癌按照病理类型可分为两类:小细胞肺癌和非小细胞肺癌(nonsmall cell lung cancer,NSCLC),…

[HTML][HTML] 常见癌症生物标记物在分子诊断中的应用

韩建冬, 王美玲, 杜艳青, 梁凤英, 额尔敦 - Medical Diagnosis, 2019 - hanspub.org
… increasing evidence that target-based drugs are only active … in melanoma in non-small cell
lung cancer are clear examples … novel driving molecule changes and the availability of drugs

丝氨酸和精氨酸丰富的剪接因子1: 神经保护和其他疾病的潜在靶标

AM Sandoval-Castellanos, A Bhargava… - 中国神经再生研究 …, 2023 - sjzsyj.com.cn
… They showed that the environment in which the tumor is growing … to reduce non-small cell
lung cancer proliferation and stimulate … network to reveal novel targets for the pathogenesis of …

非小细胞肺癌中MET 抑制剂的耐药机制及应对策略研究进展

韩森, 马旭, 方健 - 中国肿瘤临床, 2020 - cjco.cn
tumor-driving gene for non-small cell lung cancer (NSCLC). … thereby expanding the field of
novel drug development. Preliminary stud… mutational landscape determines sensitivity to PD-1 …

[HTML][HTML] 晚期非小细胞肺癌ALK 融合基因及其他少见驱动基因阳性靶向治疗进展

张权, 张树才 - Chinese Journal of Lung Cancer, 2017 - ncbi.nlm.nih.gov
… in advanced non-small cell lung cancer (NSCLC) with positive driver genes. This area of …
with novel target discoveries, novel drug development, and use of novel combination treatments

[HTML][HTML] 利用高通量转录组测序对肺鳞癌基因型的

雄英, 李明珍, 张攀攀, 张理意, 杨跃 - … Journal of Lung Cancer, 2017 - ncbi.nlm.nih.gov
lung cancer, and researchers have known less targets for this … metastasis that provide novel
idea for lung cancer therapy. … 其中非小细胞肺癌(non-small cell lung cancer, NSCLC)的发病…

[HTML][HTML] RET 融合型非小细胞肺癌的研究进展

郑玉军, 姜巍, 陈东妍, 李颜君, 代璐璐… - … of Lung Cancer, 2021 - ncbi.nlm.nih.gov
… biology, the treatment of non-small cell lung cancer (NSCLC) … brought the treatment of
NSCLC into a promising target era. … Recently, new high selective RET inhibitors blu-667 and loxo…

[HTML][HTML] PDX 模型在肿瘤研究中的应用

古钎林, 石文贵, 焦作义 - 生物医学转化, 2020 - swyxzh.ijournals.cn
… Establish ment of patient-derived non-small cell lung cancer … of new anti-tumor drugs is
emergent, but most of drugs are … Patient-derived tumor xenograft (PDX) is one of the novel tumor

[HTML][HTML] 肿瘤微环境内的免疫细胞、 PD-1 与EGFR-TKIs 疗效关系新进展

袁世洋, 徐慧, 谢军平 - Chinese Journal of Lung Cancer, 2017 - ncbi.nlm.nih.gov
… 的晚期非小细胞肺癌(non-small cell lung cancer, NSCLC)患者的… Tumor microenvironment is
the internal environment for the … seek new targets, and further improve the anti-tumor efficacy …